Dolphin
Senior Member (Voting Rights)
https://arxiv.org/abs/2404.04345
[Submitted on 5 Apr 2024]
System and Method to Determine ME/CFS and Long COVID Disease Severity Using a Wearable Sensor
Yifei Sun, Suzanne D. Vernon, Shad Roundy
Objective:
We present a simple parameter, calculated from a single wearable sensor, that can be used to objectively measure disease severity in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) or Long COVID. We call this parameter UpTime.
Methods:
Prior research has shown that the amount of time a person spends upright, defined as lower legs vertical with feet on the floor, correlates strongly with ME/CFS disease severity. We use a single commercial inertial measurement unit (IMU) attached to the ankle to calculate the percentage of time each day that a person spends upright (i.e., UpTime) and number of Steps/Day. As Long COVID shares symptoms with ME/CFS, we also apply this method to determine Long COVID disease severity. We performed a trial with 55 subjects broken into three cohorts, healthy controls, ME/CFS, and Long COVID. Subjects wore the IMU on their ankle for a period of 7 days. UpTime and Steps/Day were calculated each day and results compared between cohorts.
Results:
UpTime effectively distinguishes between healthy controls and subjects diagnosed with ME/CFS (p=0.00004) and between healthy controls and subjects diagnosed with Long COVID (p=0.01185). Steps/Day did distinguish between controls and subjects with ME/CFS (p=0.01) but did not distinguish between controls and subjects with Long COVID (p=0.3).
Conclusion:
UpTime is an objective measure of ME/CFS and Long COVID severity. UpTime can be used as an objective outcome measure in clinical research and treatment trials.
Significance:
Objective assessment of ME/CFS and Long COVID disease severity using UpTime could spur development of treatments by enabling the effect of those treatments to be easily measured.
[Submitted on 5 Apr 2024]
System and Method to Determine ME/CFS and Long COVID Disease Severity Using a Wearable Sensor
Yifei Sun, Suzanne D. Vernon, Shad Roundy
Objective:
We present a simple parameter, calculated from a single wearable sensor, that can be used to objectively measure disease severity in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) or Long COVID. We call this parameter UpTime.
Methods:
Prior research has shown that the amount of time a person spends upright, defined as lower legs vertical with feet on the floor, correlates strongly with ME/CFS disease severity. We use a single commercial inertial measurement unit (IMU) attached to the ankle to calculate the percentage of time each day that a person spends upright (i.e., UpTime) and number of Steps/Day. As Long COVID shares symptoms with ME/CFS, we also apply this method to determine Long COVID disease severity. We performed a trial with 55 subjects broken into three cohorts, healthy controls, ME/CFS, and Long COVID. Subjects wore the IMU on their ankle for a period of 7 days. UpTime and Steps/Day were calculated each day and results compared between cohorts.
Results:
UpTime effectively distinguishes between healthy controls and subjects diagnosed with ME/CFS (p=0.00004) and between healthy controls and subjects diagnosed with Long COVID (p=0.01185). Steps/Day did distinguish between controls and subjects with ME/CFS (p=0.01) but did not distinguish between controls and subjects with Long COVID (p=0.3).
Conclusion:
UpTime is an objective measure of ME/CFS and Long COVID severity. UpTime can be used as an objective outcome measure in clinical research and treatment trials.
Significance:
Objective assessment of ME/CFS and Long COVID disease severity using UpTime could spur development of treatments by enabling the effect of those treatments to be easily measured.
Last edited: